Next Generation of CSHP Committees Reflect New Strategic Direction


Much has changed within CSHP’s committee structure, representing nearly two years of review and planning to make the work of the committees as effective as possible under new strategic direction. At the fall 2019 Board meetings in Dartmouth, NS the CSHP Board of Directors voted in favour of a committee restructuring proposal led by Past Presidential Officer, Patrick Fitch. A chart of the resulting reconfiguration and consolidation of committees can be seen here.

Current President-Elect (Internal Portfolio) Zack Dumont is now leading the implementation of the plan. In a December letter to affected committee members, he stated, “Our goal was to focus our volunteer expertise on the strategy, direction and policy of the organization, and allocate more operational matters such as communications, brand development, and marketing to the professional team in the office.”

Past committee members have responded positively, fully supporting the change and their availability for new involvement opportunities. Work will continue either thorough the new committee restructuring or the national staff.  CEO Jody Ciufo says, “CSHP volunteers have done an incredible job on these committees in the past. Our new structure will make sure their work is focussed on their areas of expertise and leave much of the process work to our staff team. This means the results of volunteers’ input will be shared more quickly.”

One of the biggest areas of change is within Pharmacy Practice. Two new committees have been created as well as the mechanism for additional expert working groups on specific issues or policies:

  • Pharmacy Practice Vision Committee (Standing Committee)
    • This committee will be responsible for making recommendations to the Board that affect the profession as a whole, for example, pharmacy practice standards and quality, professional ethics, inter-professional collaboration, applications of technology in the medication-use process, efficiency and safety of medication-use systems, practitioner activities in public health and for individual patients and others.
  • Education and Development Committee (Standing Committee)
    • This committee will be responsible for making recommendations to the Board on topics including assessment and maintenance of competence, student education, post-graduate education and training, workforce supply and demand, evidence-based use of medicines, benefits and risks of drug products, application of drug information in practice, etc.
  • Expert Working Groups
    • Following current practice, the Board recognized the need to prepare expert-based responses to specific issues, policies or practice areas for which generalist standing committees don’t add value. Current examples are Technicians Task Force, Cannabis Task Force, and the Compounding Steering Committee whose recommendations go directly to the Board for consideration.

A new category of “Networks” has been created. “The new networks are advisory in nature and serve to share strategy and information among branches and the national association,” says Ciufo. “We are looking forward to this enhanced line of communication between the branch-identified representatives and CSHP to really target the various needs across the country.” The three initial networks are: 

  • Presidential Officer Network,
  • Membership Network, and
  • Student Network

The following committees have been disbanded:

  • Membership,
  • Advocacy,
  • Pharmacy Practice Publications Steering Committee,
  • PSN Coordinating Committee,
  • Bylaws, and
  • Excellence in Pharmacy Practice.

CSHP thanks all committee members for their previous contributions and new involvement opportunities will be publicized through subsequent issues of Interactions.